Except for obvious liver function injury, it is in accordance with our previous rat models of NAFLD with a higher expression of FASN and unchanged expression of SREBP1-c, and the difference might be due to different experimental species. This evidence concerns the gene SREBF1 and metabolic dysfunction-associated steatotic liver disease.